Extensive clinical studies have shown that the expression of u-PAR, u-PA, and its specific inhibitor PAI-1 is associated with tumour recurrence and poor survival of diverse cancer types (Werle et al, 2004; Beyer et al, 2006). The gene discussed is PLAUR; the disease is neoplasm.